June 8-11, 2023

Frankfurt, Germany

Title: Rusfertide (PTG-300) improves polycythemia vera (PV) related symptoms in PV patients

Abstract Code: P1016

Presenting Author: Andrew Kuykendall , M.D., Assistant Member, Department of Malignant Hematology, Moffitt Cancer Center

Session Date and Time: Friday, June 9, 18:00 - 19:00 CEST

Title: Pharmacokinetic and pharmacodynamic effects of rusfertide in polycythemia vera: Results from an ongoing Phase 2 study in patients with elevated hematocrit values

Abstract Code: P1048
Presenting Author: Marina Kremyanskaya , M.D., Ph.D., Assistant Professor of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

Session Date and Time: Friday, June 9 , 18:00 - 19:00 CEST

Full abstract information can be found on the EHA 2023 Hybrid Congress website at https://ehaweb.org/congress/eha2023-hybrid-congress/eha2023/.